Skip to main content

EXCLUSIVE: GenomicFX to Close its Doors in August

NEW YORK, July 25 – GenomicFX, an animal genomics company based in Austin, Tex., will close its doors in August, GenomeWeb learned Wednesday.

Company officials did not respond to calls. Gerard Davis, the CEO of Genetic Solutions, a Brisbane, Australia-based company that GenomicFX acquired in February, referred a reporter to GenomicFX. GenomicFX’s website contained only a link to Genetic Solutions.

In February, GenomicFX announced that it had licensed Incyte's LifeSeq Gold and Zooseq databases, and that Incyte would provide custom sequencing services to help build GenomicFX’s proprietary databases of cattle and swine genomic information. At the time, GenomicFX said it would create animal blood tests to help livestock breeders select animals for high quality meat production capabilities, as well as develop an identification tool to verify the breed or origin of a cut of meat. 

Genometrix, a provider of custom-designed and prefabricated microarrays, SNP genotyping services, and software tools based in The Woodlands, Tex., ceased operations on June 25.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.